Watson and acquisition target Actavis must sell 18 drugs to rivals Sandoz and Par Pharma under conditions imposed by the US Federal Trade Commission (FTC).
US CMO Ben Venue has restarted 'limited drug manufacturing' at its plant in Bedford, Ohio, but does not expect to start shipping product for several months.
Charles River Laboratories' deal with AstraZeneca may only formalise an existing relationship but a second Big Pharma accord is good news for the CRO say analysts.
Outsourcing-Pharma.com presents its weekly round-up of the latest changes, faces and places in the pharma services sector, including news from Wolters, Advanced Clinical and BIA.
SternMaid has invested €14m in its Wittenburg factory to enlarge capacity and extend the range of its products and services, involving the introduction of new fluid bed technology.
Stricter GMP requirements in Peru are increasing the time it takes to get drugs approved and may not be giving regulators any useful additional information.
in-PharmaTechnologist.com presents its weekly round up of the latest movers and shakers in the world of pharmaceuticals, including news from Cytos, Ablynx and Baxter.
Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.
in-PharmaTechnologist.com presents its weekly round-up of the new faces and changing places in the pharma biz, including news this week from BIA, Tolera and Alexar.
Scotland’s emergence as a biopharma hub – as evidenced by announcements by SAFC and Quintiles last week – is due to Government support, electronic health records and speedy trial approvals says Scottish Enterprise.
A transdermal patch technology developed by 3M Drug Delivery could lead to new injection free, compliance-boosting treatments for postmenopausal osteoporosis.
Outsourcing-Pharma.com presents its weekly round-up of the latest appointments in the pharma services industry, including news from Chiltern, Novacep and Emergent.
